![](/img/cover-not-exists.png)
Enhancement of C.E.V combination (cisplatin, epirubicin, vindesine) in advanced NSCLC by lonidamine. A phase II randomized trial
Ianniello, G.P., De Cataldis, G., Comella, P., De Vita, F., Maiorino, A., Brancaccio, L.Volume:
11
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/0169-5002(94)94271-4
Date:
June, 1994
File:
PDF, 130 KB
english, 1994